MACQUARIE GROUP LTD - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$153,000
+4.1%
256,3850.0%0.00%
Q2 2023$147,000
-18.3%
256,3850.0%0.00%
Q1 2023$180,000
-68.9%
256,3850.0%0.00%
-100.0%
Q4 2022$579,000
-31.2%
256,385
-1.0%
0.00%0.0%
Q3 2022$841,000
-15.8%
258,941
-1.5%
0.00%0.0%
Q2 2022$999,000
-29.5%
262,8490.0%0.00%0.0%
Q1 2022$1,417,000
-60.4%
262,849
-0.8%
0.00%
-66.7%
Q4 2021$3,579,000
-24.8%
264,9430.0%0.00%
-25.0%
Q3 2021$4,759,000
+3.6%
264,943
-1.0%
0.00%0.0%
Q2 2021$4,593,000
-13.0%
267,604
+1.4%
0.00%
-42.9%
Q1 2021$5,279,000
+16.8%
263,949
-0.7%
0.01%0.0%
Q4 2020$4,519,000
+2.5%
265,8020.0%0.01%0.0%
Q3 2020$4,409,000
-28.2%
265,802
+0.3%
0.01%
-36.4%
Q2 2020$6,139,000
+30.3%
265,102
+0.4%
0.01%
+10.0%
Q1 2020$4,712,000
+26.5%
263,985
+52.9%
0.01%
+100.0%
Q4 2019$3,726,000
+20.1%
172,600
+1.3%
0.01%0.0%
Q3 2019$3,103,000
-82.9%
170,400
-66.7%
0.01%
-50.0%
Q2 2019$18,189,000
+225.9%
511,200
+207.8%
0.01%0.0%
Q1 2019$5,581,000
+2.2%
166,1000.0%0.01%
-9.1%
Q4 2018$5,460,000
-46.4%
166,100
-0.5%
0.01%
-35.3%
Q3 2018$10,180,000
+26.3%
167,000
+1.2%
0.02%
+21.4%
Q2 2018$8,057,000
+389.8%
165,000
+966.0%
0.01%
+366.7%
Q1 2018$1,645,000
-16.4%
15,478
-53.0%
0.00%0.0%
Q4 2017$1,968,000
+9.3%
32,946
-78.9%
0.00%
-25.0%
Q2 2013$1,801,000155,9180.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders